Background: The use of complementary and alternative medicine for weight loss is becoming increasingly common worldwide. In overweight or obese patients, this practice could be harmful. Available data concerning the use of complementary therapies and products (CTPs) for weight loss in these patients in Colombia are limited.
INTRODUCTION
The usage of complementary and alternative medicine (CAM) in combination with or instead of standard medical care is high and continues to increase. One US study reported that the percentage of the population using CAM increased from 33.8% to 42.1% between 1990 and 1997.1 Other US studies have reported CAM use ranging from 28.9% to 62.1%. 2-4 In 1 study of ambulatory patients referred to an internist, the estimated proportion of patients who had used CAM was 85.4%. 5 In those studies, some of the reasons for using CAM reported by patients included maintaining good health 5 and preventing or treating musculoskeletal conditions, allergies, and other respiratory problems. 1,4 Patients with cancer, 6 chronic disease (eg, diabetes mellitus), 7 and other severe diseases 5,8 have reported CAM use. Some patients use CAM in addition to conventional therapy. 1,2,4 Reasons patients have cited for supplemental CAM use include discontent with medical outcomes 4,8 and the perception that CAM is harmless. 4, 9, 10 CAM use is highest in patients who are female, are nonsmokers, are physically active, have a normal body mass index (BMI), and/or eat low-fat diets with a high fruit and vegetable content, u Individuals aged 35 to 54 years with a high level of education and above-average incomes have been found to use CAM more frequently compared with the general population. 1-4,6,12 Women most commonly cite maintenance of a healthy body and mind 2,4 and weight reduction 12,13 as reasons for CAM use.
Obesity, a common chronic condition that continues to increase in prevalence (-1.1 billion adults worldwide are classified as overweight or obese), 14 is associated with a decreased life span, 15 and contributes to morbidity and mortality from a variety of secondary chronic conditions. 16, 17 The combination of caloric restriction, increased physical activity, and behavioral therapy might be an effective approach to obesity. 18 However, some patients might require pharmacotherapy or other strategies to reach their therapeutic goals) 8, 19 In a meta-analysis 2° of 79 clinical trials of diet plus pharmacotherapy (sibutramine, orlistat, fluoxetine, sertraline, bupropion, topiramate, or zonisamide) for obesity, the mean weight loss was found to be 10 kg at 1 year. However, such outcomes frequently do not meet patients' expectations, especially in those with the highest pretreatment weights. 21 This difference between expectations and outcomes might lead to patients having negative perceptions of their weight-loss therapy and a lack of motivation to adhere to the therapy. 12 As a result, patients might use CAM (in combination with conventional medical care), involving the use of diet and/or medicines plus complementary therapies and products (CTPs) for weight loss. 22-31 Most often, CTPs are used without the knowledge of a health care professional, u,22 There is little evidence of the efficacy of CTPs, 23,24,28 and their association with adverse events is a concern. 1°,22 ' 28 Information concerning the prevalence and anthropometric and biochemical parameters associated with the use of CTPs for weight loss in overweight or obese patients is limited. The objectives of this study in overweight or obese patients receiving nutritional treatment were to determine the prevalence of self-treatment with CTPs and to explore the relationship between CTP use and demographic, anthropometric, and biochemical parameters.
PATIENTS AND METHODS
This randomized, cross-sectional study was conducted at a registered dietician's office located at the Center for Nutritional Care, School of Nutrition and Dietetics, University of Antioquia, Medellin, Colombia, and at an outpatient clinic attended by a registered dietician located at the Pablo Tob6n Uribe Hospital, Medellin, Colombia. The study protocol was approved by the respective institutional review board.
Inclusion and Exclusion Criteria
Overweight (BMI, 25-30 kg/m 2) or obese (BMI, >30 kg/m 2) male and female patients aged 20 to 50 years who were receiving ambulatory nutritional treatment during 2002 were eligible for the study. Nutritional treatment comprised a low-calorie diet (500 kcal/d less than the total energy intake required to maintain body weight). The diet provided 30% of energy from fat, 55% from carbohydrates, and 15% from protein. Exercise (->30 minutes 4 times a week) was also recommended to patients. Patients with cardiovascular disease, those receiving nutritional treatment other than a calorie-restricted diet, and pregnant or breastfeeding women were excluded. Patients who prayed for health reasons were also excluded from the study.
The files of patients who met the inclusion criteria based on their medical records were numbered from 1 to 312 consecutively. Using Epi-Info version 6.04b (Centers for Disease Control and Prevention, Atlanta, Georgia), a list of random numbers was obtained. Patients whose file number coincided with the random numbers were invited to participate. Written informed voluntary consent was obtained from all of the patients who were enrolled in the study.
Methods
The primary end point was the prevalence of self-treatment with CTPs in overweight or obese patients receiving nutritional treatment, and the secondary end points were the relationships between CTP use and demographic, anthropometric, and biochemical parameters.
During a clinic visit, the prevalence of self-treatment with CTPs in combination with conventional nutritional treatment, along with demographic, anthropometric, and biochemical parameters were gathered by 2 dieticians, 1 bacteriologist, or 2 students of nutritional therapy trained in collecting such information. Also at the clinic visit, patients verified that they had not ingested food, beverages, or diuretics for a minimum of 12 hours before the visit and that they had not engaged in intense physical activity or ingested fatty foods in the 24 hours before the visit.
To determine the use of self-treatment with CTPs in combination with conventional nutritional treatment, patients were asked several questions. First, they were asked whether they had ever self-administered complementary therapies for weight loss during the past year. The patients who answered yes were then asked to specify which of the following therapies they had used: massage, bioenergy, acupuncture, electrostimulation, chiropractic, or other. They were also asked whether they had ever self-administered complementary products for weight loss during the past year. Patients who answered yes were asked to specify the type of product used---commercial diet (diets different from those of the nutritional treatment), folkloric or home remedies (infusions or boiled preparations of medicinal plants or food products), herbal medicines (medicinal plants prepared in a dosing formulation and adequately or inadequately identified), or homeopathic medicine (any composition and infinitesimal dose). [1] [2] [3] [4] [5] [6] [7] 11 To determine patients' satisfaction with their weight loss and nutritional treatment, patients were asked: "How would you qualify the weight loss reached during the nutritional treatment?" and "How would you qualify your satisfaction with the received nutritional treatment?" Answers were rated on a 6-point scale (0 = extremely unsatisfactory to 5 = very satisfactory).
Anthropometric Data
The anthropometric data were measured with excess clothing and materials removed. Weight was measured using a standard electronic scale (Platform Scale, A&D Co. Ltd., Phoenix, Arizona) with a capacity of 150 kg and accuracy _+0.05 kg. Height was measured using a standard ruler that could be used to measure up to 220 cm with an accuracy _+0.1 cm. Waist circumference (WC) and hip circumference were measured using a fiberglass tape measure (Mabis, Tokyo, Japan) with an accuracy _+0.1 cm. The mean of 2 measurements of weight and height were used. Using Quantum II (RJL Systems, Clinton Township, Michigan) the percentage of fat weight (%FW) was determined using the bioelectrical impedance technique with 4 electrodes.
BMI was classified as follows: low weight, <18.5 kg/m2; normal weight, 18.5-24.9 kg/m2; overweight, 25.0-29.9 kg/m2; and obese, >30.0 kg/m 2. Waist/hip ratio (WHR) >0.9 in men and >0.85 in women was considered higher risk. WC >102 cm in men and >89 cm in women was considered higher risk. In men, %FW was classified as follows: thin, <12%; appropriate, 12% to 15%; acceptable, >15% to 20%; and excessive, >20%. In women, %FW was classified as follows: thin, <15%; appropriate, 15% to 20%; acceptable, >20% to 25%; and excessive, >25%. 18 Patients enrolled in the study received individual care by a registered dietician concerning diet for healthy adults, as recommended by National Task Force on the Prevention and Treatment of Obesity14; and the dietician encouraged each patient to consume a nutritionally balanced, low-calorie diet (500 kcal/d less than the total energy intake required to maintain body weight) and some meal plans and daily menu options were provided.
Biochemistry
Personnel from the Bacteriology Laboratory, University of Antioquia, Medellin, Colombia, collected blood samples and performed the analyses. Because the patients did not have established cardiovascular disease (primary prevention), levels of fasting plasma glucose, 70 to 109 mg/dL; total cholesterol (TC), _<239 mg/dL; low-density lipoprotein cholesterol, _<129 mg/dL; high-density lipoprotein cholesterol, a40 mg/dL; and triglycerides, _<149 mg/dL were considered normal. 32
Statistical Analysis
Statistical analysis was performed using SPSS version 10 (SPSS Inc., Chicago, Illinois). Data are reported as mean (SD). The ~2 test was used to compare proportions, and the Student t test was used to compare means, including odds ratios (ORs) and 95% CIs. Comparisons were analyzed using a 2-tailed test. P < 0.05 was considered statistically significant. The Fisher exact test was used to compare categories that had <5 data sets.
RESULTS
One hundred five patients were selected; 94 agreed to participate and completed the study ( 
Use of Complementary Therapies and Products
Forty-nine (52.1%) patients responded that they had used weight-loss CTPs by self-treatment in addition to nutritional treatment. Specifically, 40 (42.6%) patients used complementary products, and 21 (22.3%) used complementary therapies (Table II) . Some patients reported using as many as 3 weight-loss CTPs.
Among the products, inadequately identified herbal medicines, folkloric or home remedies, and commercial diets were the most commonly used alternatives (16 In the overall study population, no significant differences in age, marital status, socioeconomic status, physical activity, associated morbidity, or educational level were found between the patients who used CTPs and those who did not. 
Anthropometric Variables and Complementary Therapy and Product Use
The anthropometric data are presented in Table I (Table I) . No association was found between any of the biochemical variables and CTP use or nonuse.
Biochemical Variables and Complementary Therapy and Product Use

DISCUSSION
The findings of this study suggest that >50% of overweight and obese patients receiving nutritional treatment use CTPs by self-treatment.
In a previous study, Blanck et a122 found that only 7% of 14,679 male and female outpatients were self-treating with CTPs. The low rate found in that study compared with that in the present study (52.1%) might have been due to the facts that (1) Blanck et a122 did not investigate the use of therapies; and (2) the study by Blanck et a122 was carried out in the general population (in obese women in that study, the prevalence was 28.4%).
The present study found an association between the use of weight-loss CTPs and a lack of satisfaction with nutritional treatment. This finding was similar to that from a recent study of CAM use the United States, 4 in which 27.7% of CAM users indicated that they believed that the conventional treatments they received were not effective. 4 Similarly, a telephone survey in 232 patients with rheumatoid arthritis found that 50% of patients used complementary therapies because they thought their conventional medication was ineffective. 8 This result differs from those from a previous study, 9 in which data did not support the hypothesis that CAM use in the United States is due to dissatisfaction with conventional treatment.
Factors that might be associated with the frequent use of CTPs in overweight and obese patients are the notable increase in CTP use (mainly herbal or nutritional supplements, folkloric remedies, massage, multivitamins, and self-care groups) in the general population, 1,4,8 the availability and accessibility of these products, 22 the low rate of fulfillment of the objectives of the nutritional treatment, the discrepancy between the expectations of the patients and the results achieved, and the difficulty in maintaining lifestyle changes. 12, 21, 23, 26 In the present study, the use of weight-loss complementary products (42.6%) was similar to that of herbal and nutritional supplements (33%) found by Gunther et a111 in a study of 61,587 participants aged 50 to 76 years who completed a self-administered questionnaire.
However, the use of herbal medicines that are not authorized in Colombia for the treatment of weight loss and/or that have fictitious product names have been important obstacles in determining the composition, effectiveness, and tolerability of these products. 28-33 The inability to study herbal medicines for these reasons, and the possibility of serious adverse events due to drug interactions, 34 might present important health risks regardless of the possible beneficial effects of these products on weight loss. [29] [30] [31] Such adverse events have occurred with chromium salts, ephedra and ephedrine, 35 caffeine and other zantic bases, 23,36 and usnic acid. 37 In addition, the possibility of adulteration of CTPs with other substances and the fact that the sale of some CTPs has been prohibited in Colombia for several years might also lead to health risks. 38,39 However, in this study, we did not ask about adverse drug events.
Among the folkloric or home remedies patients reported using in our study, only C aurantium, 3° C decumana, and T officinale have been assessed in relation to the indications and have been recommended for the treatment of obesity. 24 This situation is similar to that in herbal medicines, of which only Marrubium vulgare (horehound) and Camellia sinensis (green tea) have been evaluated in relation to the indications and have been recommended for the treatment of obesity. 24 This finding shows the need to educate patients about the possible benefits of CTPs in the treatment of obesity.
As in other studies in the general population in the United States, 1,4 in patients who were consulting an internist, we found that women used CTPs more frequently compared with men. 5 The rate of CTP use in obese women in our study was 59.6%, and, as in other studies of the use of weight-loss products 22 or herbal or nutritional preparations, 11 in women who used CTPs, those with a higher educational level used these products significantly more frequently compared with women with less education. [1] [2] [3] [4] [5] [6] [7] [8] 11 This finding is related to a concern in this group to be healthy, 3,4,11 with emphasis on appearance and body weight. 13 In women, there was no clear explanation for the finding of the association between CTP use and being single. This topic could be researched in future studies.
With the exception of the WHR, no statistically significant associations were found between anthropometric indicators and CTP use. Several reviews assessing the effects of CTPs in the treatment of obesity found significant improvements in WC and WHR in patients who used CTPs, but concluded that more and better evidence of the benefits of these products 22,23,28 or therapies 27 was needed.
In the present study, the fact that the %FW was higher in CTP users suggests that these products might affect the distribution of corporal fat, which might mean associated health risks. 15,32 This fat should be examined in a prospective, longitudinal study designed to compare the efficacy and tolerability of nutritional treatment plus CTPs versus nutritional treatment alone.
The finding in our study that patients who used CTPs had significantly lower TC levels compared with patients who did not use CTPs might have been the result of better habits and healthier lifestyles in CAM users. 11, 13 Health care professionals should investigate and analyze the benefits and risks of CTP use and document their findings in detail. Studies designed to determine the benefits and risks associated with CTP use in overweight and obese patients are needed.
Study Limitations
Because this study had several limitations, the results must be interpreted with caution. First, because this was a cross-sectional study with a small number of patients, causal associations could not be established. Such relationships could help to document the effectiveness or lack of effectiveness of the use of weight-loss CTPs. Second, some patients did not adequately identify the type of product that they were using, which reflected potential recall bias and limited a detailed review of potential benefits and risks of CTP use. Third, multiple statistical analyses were conducted in a small number of patients in the study. In addition, the exclusion of an analysis of prayer for health might have resulted in an underestimation of the percentage of patients who used CAM. Finally, adverse events were not recorded.
CONCLUSIONS
In the small group of overweight and obese patients in this study, 52.1% used CTPs. In obese women, those with a higher educational level and/or who were single were more likely to use CTPs. Patients were also more likely to use CTPs if they had a negative view of their current nutritional therapy.
